EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H22N2O4 |
| Net Charge | 0 |
| Average Mass | 378.428 |
| Monoisotopic Mass | 378.15796 |
| SMILES | COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O |
| InChI | InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1 |
| InChIKey | OUJTZYPIHDYQMC-LJQANCHMSA-N |
| Roles Classification |
|---|
| Biological Role: | antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | antifibrotic agent Any agent which acts to reduce fibrosis. anti-asthmatic agent Any compound that has anti-asthmatic effects. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ambrisentan (CHEBI:135949) has role anti-anaemic agent (CHEBI:75835) |
| ambrisentan (CHEBI:135949) has role anti-asthmatic agent (CHEBI:65023) |
| ambrisentan (CHEBI:135949) has role antifibrotic agent (CHEBI:233423) |
| ambrisentan (CHEBI:135949) has role antihypertensive agent (CHEBI:35674) |
| ambrisentan (CHEBI:135949) has role antiviral agent (CHEBI:22587) |
| ambrisentan (CHEBI:135949) has role cardiovascular drug (CHEBI:35554) |
| ambrisentan (CHEBI:135949) is a diarylmethane (CHEBI:51614) |
| Synonyms | Source |
|---|---|
| Ambrisentan | ChEMBL |
| GSK-1325760 | ChEMBL |
| GSK1325760 | ChEMBL |
| GSK-1325760A | ChEMBL |
| GSK1325760A | ChEMBL |
| letairis | DrugCentral |
| Brand Name | Source |
|---|---|
| Ambrisentan mylan | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 4337 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| CAS:177036-94-1 | DrugCentral |
| Citations |
|---|